biotech · Plaque Psoriasis · Rheumatoid Arthritis · CANF
Can Fite Biopharma
Can-Fite BioPharma
Can Fite Biopharma is a biotech organization headquartered in RAMAT GAN, L3, USA. It trades on NYSE under ticker CANF. Primary therapeutic focus areas include Plaque Psoriasis, Rheumatoid Arthritis, Hepatocellular Carcin
10 Bareket Street, פ"ת, IL, RAMAT GAN, L3, USA HQ
9 Employees
Public company Type
CANF · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10 Bareket Street, פ"ת, IL, RAMAT GAN, L3, USA
- Employees
- 9
- Programs
- 20
- Drugs
- 4
- Patents
- 23
CF101
Phase 3 · small molecule · Keratoconjunctivitis Sicca
CF101 for Keratoconjunctivitis Sicca is a Phase 3 program (small_molecule) at Can-Fite BioPharma with 2 ClinicalTrials.gov record(s).
Internal code CF101-201KCS
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Can-Fite BioPharma
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Keratoconjunctivitis Sicca
- Status
- completed
- Trials
- 2